Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease Understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Segments and Regions Considered
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Market Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Secondary Sources
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Primary Sources
2.1.2.2 Key Objectives of Primary Research
2.1.2.3 Key Data from Primary Sources
2.1.2.4 Key Industry Insights
2.1.2.5 Breakdown of Primaries
2.2 Research Design
2.3 Market Size Estimation
2.3.1 Supply-Side Analysis (Revenue Share Analysis)
2.3.2 Bottom-Up Approach: End-user Adoption
2.3.2.1 Top-Down Assessment of Parent Market
2.3.2.2 Company Presentations and Primary Interviews
2.4 Data Triangulation
2.5 Study Assumptions
2.5.1 Market Sizing Assumptions
2.5.2 Research Assumptions
2.6 Risk Assessment
2.7 Research Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations

4.1 Artificial Intelligence in Drug Discovery Market Overview
4.2 North America: Artificial Intelligence in Drug Discovery Market, by End-user and Country (2023)
4.3 Artificial Intelligence in Drug Discovery Market: Geographic Growth Opportunities
4.4 Artificial Intelligence in Drug Discovery Market: Regional Mix
4.5 Artificial Intelligence in Drug Discovery Market: Developed vs. Emerging Markets

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Cross-Industry Collaborations and Partnerships
5.2.1.2 Rising Need to Reduce Time and Cost of Drug Discovery and Development
5.2.1.3 Patent Expiry of Drugs and Need for Effective New Leads
5.2.1.4 Growing Utilization of AI to Predict Drug-Target Interactions for Cancer Therapy
5.2.1.5 Integration of AI-Assisted Multiomics in Drug Discovery
5.2.1.6 Growing Focus on Rare Disease Treatments for Orphan Drug Development
5.2.2 Restraints
5.2.2.1 Shortage of AI Workforce and Ambiguous Regulatory Guidelines for Medical Software
5.2.3 Opportunities
5.2.3.1 Leveraging AI for Accelerated Biotech Drug Discovery
5.2.3.2 Increased Focus on Drug Discovery in Emerging Economies
5.2.3.3 Focus on Developing Human-Aware AI Systems
5.2.3.4 Growing Use of AI in Single-Cell Analysis
5.2.3.5 Easy Identification of Biomarker and Disease Subtypes from Single-Cell Data
5.2.3.6 High Demand for Precision and Personalized Medicines
5.2.4 Challenges
5.2.4.1 Limited Availability of Quality Data Sets
5.2.4.2 Lack of Advanced AI Tools and Training Data Sets
5.2.4.3 Computational Constraints of Advanced AI Models
5.2.4.4 Lack of High-Quality Data Sets for Model Training
5.3 Trends/Disruptions Impacting Customer's Business
5.4 Industry Trends
5.4.1 Evolution of AI in Drug Discovery
5.4.2 Computer-Aided Drug Design and Artificial Intelligence
5.5 Ecosystem Analysis
5.6 Supply Chain Analysis
5.7 Technology Analysis
5.7.1 Key Technologies
5.7.1.1 Dry Lab Services
5.7.1.2 Wet Lab Services
5.7.1.2.1 Chemistry Software and Services
5.7.1.2.2 Biology Software and Services
5.7.1.2.2.1 Single-Cell Analysis
5.7.2 Complementary Technologies
5.7.2.1 High-Performance Computing
5.7.2.2 Next-Generation Sequencing
5.7.2.3 Real-World Evidence/Real-World Data
5.7.3 Adjacent Technologies
5.7.3.1 Cloud Computing
5.7.3.2 Blockchain Technologies
5.7.3.3 Internet of Things
5.8 Regulatory Landscape
5.8.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.8.2 Regulatory Framework
5.9 Pricing Analysis
5.9.1 Indicative Selling Price for Drug Discovery Software and Services, by Region
5.9.2 Indicative Pricing Analysis, by Process
5.10 Porter's Five Forces Analysis
5.10.1 Intensity of Competitive Rivalry
5.10.2 Bargaining Power of Buyers
5.10.3 Threat of Substitutes
5.10.4 Threat of New Entrants
5.10.5 Bargaining Power of Suppliers
5.11 Key Stakeholders and Buying Criteria
5.11.1 Key Stakeholders in Buying Process
5.11.2 Key Buying Criteria
5.12 Patent Analysis
5.12.1 Patent Publication Trends
5.12.2 Jurisdiction Analysis: Top Applicant Countries for Artificial Intelligence in Drug Discovery
5.12.3 Major Patents in Artificial Intelligence in Drug Discovery Market
5.13 Unmet Needs and Key Pain Points
5.13.1 Unmet Needs
5.13.2 Single-Cell Analysis Landscape: Key Challenges and Pain Points in Drug Discovery
5.13.3 End-user Expectations
5.14 Key Conferences & Events, 2024-2025
5.15 Case Study Analysis
5.16 Business Model Analysis
5.17 Investment and Funding Scenario
5.18 Impact of AI/Generative AI on Artificial Intelligence in Drug Discovery Market
5.18.1 Top Use Cases and Market Potential
5.18.1.1 Key Use Cases
5.18.2 Case Studies of AI/Generative AI Implementation
5.18.2.1 Case Study 1: Accelerated Drug Discovery with Generative AI and Streamlined Workflows
5.18.2.2 Case Study 2: Accelerating Small-Molecule Drug Discovery with Generative AI
5.18.3 Impact of AI/Generative AI on Interconnected and Adjacent Ecosystems
5.18.3.1 AI in Drug Discovery Market
5.18.3.2 Genomics and Bioinformatics Market
5.18.3.3 Life Science Analytics Market
5.18.4 User Readiness and Impact Assessment
5.18.4.1 User Readiness
5.18.4.1.1 Pharmaceutical Companies
5.18.4.1.2 Biotechnology Companies
5.18.4.2 Impact Assessment
5.18.4.2.1 User A: Pharmaceutical Companies
5.18.4.2.1.1 Implementation
5.18.4.2.1.2 Impact
5.18.4.2.2 User B: Biotechnology Companies
5.18.4.2.2.1 Implementation
5.18.4.2.2.2 Impact
5.19 Artificial Intelligence-Derived Clinical Assets

6.1 Introduction
6.2 Target Identification & Selection
6.2.1 Increased Demand for Personalized Medicines and High Investment in Pharmaceutical R&D to Fuel Market Growth
6.3 Target Validation
6.3.1 Rising Emphasis on Avoiding Late-Stage Failure in Drug Discovery to Boost Market Growth
6.4 Hit Identification & Prioritization
6.4.1 Need for Large-Scale Data Analysis to Drive Adoption
6.5 Hit-To-Lead Identification/Lead Generation
6.5.1 Hit-To-Lead Identification/Lead Generation to Improve New Drug Potency Without Increasing Lipophilicity
6.6 Lead Optimization
6.6.1 Need for Transparent Presentation and Analysis to Boost Market Growth
6.7 Candidate Selection & Validation
6.7.1 High Possibility of Clinical Drug Failure to Spur Adoption of Candidate Validation Services

7.1 Introduction
7.2 Understanding Diseases
7.2.1 Increased Focus on Understanding Diseases to Improve Research Data Quality and Quantity
7.3 Drug Repurposing
7.3.1 Increasing Need for Cost-Effective Treatments and Rising Availability of Biomedical Data to Aid Market Growth
7.4 De Novo Drug Design
7.4.1 Small-Molecule Design
7.4.1.1 Increasing Use of Virtual Screening and Simulation Techniques to Drive Growth
7.4.2 Vaccine Design
7.4.2.1 Availability of Well-Validated AI Tools to Boost Market Growth
7.4.3 Antibody & Other Biologics Design
7.4.3.1 Advancements in Protein Modeling to Propel Segment Growth
7.5 Drug Optimization
7.5.1 Small-Molecule Optimization
7.5.1.1 Leveraging Generative Models for Identifying Potential Modifications in Molecular Structures to Aid Market Growth
7.5.2 Vaccine Optimization
7.5.2.1 Effectively Predicting Vaccine Formulations and Adjusting Delivery Vectors to Drive Growth
7.5.3 Antibody & Other Biologics Optimization
7.5.3.1 Increasing Adoption of Machine Learning for Predicting Protein Structures to Augment Segment Growth
7.6 Safety & Toxicity
7.6.1 Focus on Advanced Off-Target Effect Prediction, Pk/Pd Simulation, and Qsp Modeling to Drive Market

8.1 Introduction
8.2 Oncology
8.2.1 High Prevalence of Cancer and Shortage of Effective Oncology Drugs to Propel Market Growth
8.3 Infectious Diseases
8.3.1 Rising Epidemic Outbreaks to Boost Drug Discovery Activity
8.4 Neurology
8.4.1 Complex Disease Diagnosis and Treatment to Increase Adoption of Artificial Intelligence in Drug Discovery
8.5 Metabolic Diseases
8.5.1 Role of Artificial Intelligence in Uncovering Small-Molecule Therapies to Drive Adoption
8.6 Cardiovascular Diseases
8.6.1 Sedentary Lifestyles and High Prevalence of Obesity to Increase Novel Drug Development for Cardiac Diseases
8.7 Immunology
8.7.1 Growing Drug Pipeline for Immunological Disorders to Favor Market Growth
8.8 Mental Health Disorders
8.8.1 Increased Occurrence of Mental Health Diseases in Developed Economies to Spur Market Growth
8.9 Other Therapeutic Areas

9.1 Introduction
9.2 End-To-End Solution Providers
9.2.1 End-To-End Solution Providers to Reduce Need for Multiple Vendors and Accelerate Workflows
9.3 Niche/Point Solution Providers
9.3.1 Accurate, Cost-Effective, and Less Time Consumption to Propel Market Growth
9.4 AI Technology Providers
9.4.1 Specialized AI Capabilities with Full-Service Management to Support Market Growth
9.5 Business Process Service Providers
9.5.1 Better Accessibility of High-Quality Tools and Lower Drug Development Costs to Aid Market Growth

10.1 Introduction
10.2 Machine Learning
10.2.1 Deep Learning
10.2.1.1 Reduced Number of Errors and Consistent Management of Data to Augment Market Growth
10.2.1.2 Convolutional Neural Networks
10.2.1.3 Recurrent Neural Networks
10.2.1.4 Generative Adversarial Networks
10.2.1.5 Graph Neural Networks
10.2.1.6 Other Deep Learning Technologies
10.2.2 Supervised Learning
10.2.2.1 Supervised Learning to Predict Drug Repositioning and Manage High-Dimensional Datasets
10.2.3 Reinforcement Learning
10.2.3.1 Need to Accelerate New Molecules and Maximize Performance to Augment Segment Growth
10.2.4 Unsupervised Learning
10.2.4.1 Unsupervised Learning to Perform Complex Tasks, Uncover Potential Drug Candidates, and Optimize Lead Compounds
10.2.5 Other Machine Learning Technologies
10.3 Natural Language Processing
10.3.1 Natural Language Processing to Identify Information Within Unstructured Data and Accelerate Drug Discovery
10.4 Context-Aware Processing & Computing
10.4.1 Context-Aware Computing to Improve Predictions of Patient-Specific Drug Responses and Optimize Therapeutic Interventions
10.5 Computer Vision
10.5.1 Computer Vision to Enhance Drug Discovery Through Advanced Image Processing
10.6 Image Analysis
10.6.1 Better Drug Discovery Through Image Processing Techniques to Support Market Growth

11.1 Introduction
11.2 On-Premises Deployment
11.2.1 Provision of Multi-Vendor Architecture and Security Benefits to Drive Market
11.3 Cloud-based Deployment
11.3.1 Focus on Research Collaborations and Elimination of Software and Hardware Purchasing Costs to Drive Market
11.4 Saas-based Deployment
11.4.1 Lower Costs, Better Security, and Easier Access to Augment Market Growth

12.1 Introduction
12.2 Pharmaceutical & Biotechnology Companies
12.2.1 Rising Demand for Cost-Effective Drug Development to Propel Market Growth
12.3 Contract Research Organizations
12.3.1 Rising Need for Outsourcing in Pharmaceutical & Biotechnology Industries to Aid Market Growth
12.4 Research Centers and Academic & Government Institutes
12.4.1 Focus on Developing Therapeutic Strategies and Innovative Approaches in Drug Discovery to Aid Market Growth

13.1 Introduction
13.2 North America
13.2.1 Macroeconomic Outlook for North America
13.2.2 US
13.2.2.1 US to Dominate North American Market During Study Period
13.2.3 Canada
13.2.3.1 Emergence of New AI-based Startups and High Health Expenditure to Support Market Growth
13.3 Europe
13.3.1 Macroeconomic Outlook for Europe
13.3.2 UK
13.3.2.1 Favorable Government R&D Funding to Augment Market Growth
13.3.3 Germany
13.3.3.1 Presence of Advanced Medical Infrastructure and High Focus on Personalized Medicines to Drive Market
13.3.4 France
13.3.4.1 Strong Government Support and Favorable Strategies to Propel Market Growth
13.3.5 Italy
13.3.5.1 Advanced Pharmaceutical Industry and Increased Focus on Life Science R&D to Fuel Market Growth
13.3.6 Spain
13.3.6.1 Favorable Government Initiatives and High Investments by Pharmaceutical Companies to Boost Market Growth
13.3.7 Rest of Europe
13.4 Asia-Pacific
13.4.1 Macroeconomic Outlook for Asia-Pacific
13.4.2 Japan
13.4.2.1 High Geriatric Population and Advanced Pharmaceutical Research to Boost Market Growth
13.4.3 China
13.4.3.1 Increasing Demand for Generics and Rising Government Investments to Propel Market Growth
13.4.4 India
13.4.4.1 Developed IT Infrastructure and Favorable Government Initiatives to Spur Market Growth
13.4.5 Rest of Asia-Pacific
13.5 Latin America
13.5.1 Macroeconomic Outlook for Latin America
13.5.2 Brazil
13.5.2.1 Growing Biotechnology Sector and Increasing Governmental Initiatives to Boost Market Growth
13.5.3 Mexico
13.5.3.1 Favorable Government Initiatives and High Investments by Pharmaceutical Companies to Support Market Growth
13.5.4 Rest of Latin America
13.6 Middle East & Africa
13.6.1 Macroeconomic Outlook for Middle East & Africa
13.6.2 GCC Countries
13.6.2.1 Increasing Emphasis on Personalized Medicines and Developing Healthcare Infrastructure to Drive Market
13.6.3 Rest of Middle East & Africa

14.1 Introduction
14.2 Key Player Strategy/Right to Win
14.2.1 Overview of Strategies Adopted by Key Players in Artificial Intelligence in Drug Discovery Market
14.3 Revenue Analysis, 2019-2023
14.4 Market Share Analysis, 2023
14.4.1 Ranking of Key Market Players
14.5 Company Evaluation Matrix: Key Players, 2023
14.5.1 Stars
14.5.2 Emerging Leaders
14.5.3 Pervasive Players
14.5.4 Participants
14.5.5 Company Footprint: Key Players, 2023
14.5.5.1 Company Footprint
14.5.5.2 Use Case Footprint
14.5.5.3 Process Footprint
14.5.5.4 Therapeutic Area Footprint
14.5.5.5 Player Type Footprint
14.5.5.6 Deployment Mode Footprint
14.5.5.7 Region Footprint
14.6 Company Evaluation Matrix: Startups/SMEs, 2023
14.6.1 Progressive Companies
14.6.2 Responsive Companies
14.6.3 Dynamic Companies
14.6.4 Starting Blocks
14.6.5 Competitive Benchmarking: Startups/SMEs, 2023
14.7 Company Valuation and Financial Metrics
14.7.1 Financial Metrics
14.7.2 Company Valuation
14.8 Brand/Product Comparison
14.9 Competitive Scenario
14.9.1 Product and Solution Launches
14.9.2 Deals
14.9.3 Expansions
14.9.4 Other Developments

15.1 Key Players
15.1.1 Nvidia Corporation
15.1.1.1 Business Overview
15.1.1.2 Products/Services/Solutions Offered
15.1.1.3 Recent Developments
15.1.1.3.1 Product and Service Launches
15.1.1.3.2 Deals
15.1.1.4 Analyst's View
15.1.1.4.1 Right to Win
15.1.1.4.2 Strategic Choices
15.1.1.4.3 Weaknesses and Competitive Threats
15.1.2 Exscientia
15.1.2.1 Business Overview
15.1.2.2 Products/Services/Solutions Offered
15.1.2.3 Recent Developments
15.1.2.3.1 Solution Launches
15.1.2.3.2 Deals
15.1.2.3.3 Expansions
15.1.2.3.4 Other Developments
15.1.2.4 Analyst's View
15.1.2.4.1 Right to Win
15.1.2.4.2 Strategic Choices
15.1.2.4.3 Weaknesses and Competitive Threats
15.1.3 Google
15.1.3.1 Business Overview
15.1.3.2 Products/Services/Solutions Offered
15.1.3.3 Recent Developments
15.1.3.3.1 Solution Launches
15.1.3.3.2 Deals
15.1.3.3.3 Expansions
15.1.3.4 Analyst's View
15.1.3.4.1 Right to Win
15.1.3.4.2 Strategic Choices
15.1.3.4.3 Weaknesses and Competitive Threats
15.1.4 Recursion
15.1.4.1 Business Overview
15.1.4.2 Products/Services/Solutions Offered
15.1.4.3 Recent Developments
15.1.4.3.1 Solution Launches
15.1.4.3.2 Deals
15.1.4.3.3 Expansions
15.1.4.4 Analyst's View
15.1.4.4.1 Right to Win
15.1.4.4.2 Strategic Choices Made
15.1.4.4.3 Weaknesses and Competitive Threats
15.1.5 Insilico Medicine
15.1.5.1 Business Overview
15.1.5.2 Products/Services/Solutions Offered
15.1.5.3 Recent Developments
15.1.5.3.1 Product and Solution Launches and Developments
15.1.5.3.2 Deals
15.1.5.3.3 Other Developments
15.1.5.4 Analyst's View
15.1.5.4.1 Right to Win
15.1.5.4.2 Strategic Choices
15.1.5.4.3 Weaknesses and Competitive Threats
15.1.6 Schrödinger, Inc.
15.1.6.1 Business Overview
15.1.6.2 Products/Services/Solutions Offered
15.1.6.3 Recent Developments
15.1.6.3.1 Deals
15.1.6.3.2 Other Developments
15.1.7 Benevolentai
15.1.7.1 Business Overview
15.1.7.2 Products/Services/Solutions Offered
15.1.7.3 Recent Developments
15.1.7.3.1 Deals
15.1.8 Microsoft Corporation
15.1.8.1 Business Overview
15.1.8.2 Products/Services/Solutions Offered
15.1.8.3 Recent Developments
15.1.8.3.1 Deals
15.1.9 Atomwise Inc.
15.1.9.1 Business Overview
15.1.9.2 Products/Services/Solutions Offered
15.1.9.3 Recent Developments
15.1.9.3.1 Deals
15.1.10 Illumina, Inc.
15.1.10.1 Business Overview
15.1.10.2 Products/Services/Solutions Offered
15.1.10.3 Recent Developments
15.1.10.3.1 Solution Launches
15.1.10.3.2 Deals
15.1.11 Numedii, Inc.
15.1.11.1 Business Overview
15.1.11.2 Products/Services/Solutions Offered
15.1.12 Xtalpi Inc.
15.1.12.1 Business Overview
15.1.12.2 Products/Services/Solutions Offered
15.1.12.3 Recent Developments
15.1.12.3.1 Deals
15.1.13 Iktos
15.1.13.1 Business Overview
15.1.13.2 Products/Services/Solutions Offered
15.1.13.3 Recent Developments
15.1.13.3.1 Deals
15.1.13.3.2 Other Developments
15.1.14 Tempus
15.1.14.1 Business Overview
15.1.14.2 Products/Services/Solutions Offered
15.1.14.3 Recent Developments
15.1.14.3.1 Solution Launches
15.1.14.3.2 Deals
15.1.14.3.3 Expansions
15.1.14.3.4 Other Developments
15.1.15 Deep Genomics
15.1.15.1 Business Overview
15.1.15.2 Products/Services/Solutions Offered
15.1.15.3 Recent Developments
15.1.15.3.1 Solution Launches
15.1.15.3.2 Deals
15.1.15.3.3 Other Developments
15.1.16 Verge Genomics
15.1.16.1 Business Overview
15.1.16.2 Products/Services/Solutions Offered
15.1.16.3 Recent Developments
15.1.16.3.1 Deals
15.1.17 Benchsci
15.1.17.1 Business Overview
15.1.17.2 Products/Services/Solutions Offered
15.1.17.3 Recent Developments
15.1.17.3.1 Solution Launches
15.1.17.3.2 Deals
15.1.17.3.3 Other Developments
15.1.18 Insitro
15.1.18.1 Business Overview
15.1.18.2 Products/Services/Solutions Offered
15.1.18.3 Recent Developments
15.1.18.3.1 Deals
15.1.18.3.2 Other Developments
15.1.19 Valo Health
15.1.19.1 Business Overview
15.1.19.2 Products/Services/Solutions Offered
15.1.19.3 Recent Developments
15.1.19.3.1 Deals
15.1.19.3.2 Other Developments
15.1.20 Bpgbio, Inc.
15.1.20.1 Business Overview
15.1.20.2 Products/Services/Solutions Offered
15.1.20.3 Recent Developments
15.1.20.3.1 Deals
15.1.21 Merck KGaA
15.1.21.1 Business Overview
15.1.21.2 Products/Services/Solutions Offered
15.1.21.3 Recent Developments
15.1.21.3.1 Solution Launches
15.1.21.3.2 Deals
15.1.21.3.3 Expansions
15.1.21.3.4 Other Developments
15.2 Other Players
15.2.1 Predictive Oncology
15.2.2 Iqvia Inc.
15.2.3 Tencent Holdings Limited
15.2.4 Cytoreason Ltd.
15.2.5 Owkin, Inc.
15.2.6 Cloud Pharmaceuticals
15.2.7 Evaxion Biotech A/S
15.2.8 Standigm Inc.
15.2.9 Bioage Labs
15.2.10 Envisagenics
15.2.11 Abcellera
15.2.12 Centella

16.1 Discussion Guide
16.2 Knowledgestore: The Subscription Portal
16.3 Customization Options

Table 1 Artificial Intelligence in Drug Discovery Market: Inclusions and Exclusions
Table 2 Exchange Rates Utilized for Conversion to USD, 2021-2023
Table 3 Artificial Intelligence in Drug Discovery Market: Factor Analysis
Table 4 Artificial Intelligence in Drug Discovery Market: Market Sizing Assumptions
Table 5 Artificial Intelligence in Drug Discovery Market: Risk Assessment
Table 6 Artificial Intelligence in Drug Discovery Market: Impact Analysis
Table 7 Indicative List of Collaborations and Partnerships, 2021-2023
Table 8 Indicative List of Drugs Losing Patents in 2023 and 2024
Table 9 Artificial Intelligence in Drug Discovery Market: Role in Ecosystem
Table 10 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 North America: Regulatory Framework
Table 16 Europe: Regulatory Framework
Table 17 Asia-Pacific: Regulatory Framework
Table 18 Middle East & Africa: Regulatory Framework
Table 19 Latin America: Regulatory Framework
Table 20 Artificial Intelligence in Drug Discovery Market: Indicative Selling Price, by Region, 2021-2023
Table 21 Artificial Intelligence in Drug Discovery Market: Indicative Pricing, by Process, 2023
Table 22 Artificial Intelligence in Drug Discovery Market: Porter's Five Forces Analysis
Table 23 Influence of Stakeholders on Buying Process of Top Three End-users (%)
Table 24 Key Buying Criteria for Top Three End-users
Table 25 Jurisdiction Analysis of Top Applicant Countries for Artificial Intelligence in Drug Discovery
Table 26 Artificial Intelligence in Drug Discovery Market: List of Patents/Patent Applications
Table 27 Artificial Intelligence in Drug Discovery Market: Key Conferences & Events, January 2024-December 2025
Table 28 Case Study 1: Leveraging AI-Driven Precision Medicine to Identify Patient Subtypes and Novel Targets in Inflammatory Bowel Disease
Table 29 Case Study 2: Artificial Intelligence-Driven Drug Discovery and Co-Development
Table 30 Case Study 3: Advancing Gene Therapy for Rare Neurological Diseases
Table 31 Case Study 4: Artificial Intelligence Design and Optimization of Exs4318
Table 32 Case Study 5: Artificial Intelligence-Driven Design and Clinical Evaluation of Gtaexs617
Table 33 Key Artificial Intelligence-Derived Clinical Assets, by Company
Table 34 Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 35 Artificial Intelligence in Drug Discovery Market for Target Identification & Selection, by Region, 2022-2029 (USD Million)
Table 36 Artificial Intelligence in Drug Discovery Market for Target Validation, by Region, 2022-2029 (USD Million)
Table 37 Artificial Intelligence in Drug Discovery Market for Hit Identification & Prioritization, by Region, 2022-2029 (USD Million)
Table 38 Artificial Intelligence in Drug Discovery Market for Hit-To-Lead Identification/Lead Generation, by Region, 2022-2029 (USD Million)
Table 39 Artificial Intelligence in Drug Discovery Market for Lead Optimization, by Region, 2022-2029 (USD Million)
Table 40 Artificial Intelligence in Drug Discovery Market for Candidate Selection & Validation, by Region, 2022-2029 (USD Million)
Table 41 Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 42 Artificial Intelligence in Drug Discovery Market for Understanding Diseases, by Region, 2022-2029 (USD Million)
Table 43 Artificial Intelligence in Drug Discovery Market for Drug Repurposing, by Region, 2022-2029 (USD Million)
Table 44 Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 45 Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Region, 2022-2029 (USD Million)
Table 46 Small-Molecule Design Market, by Region, 2022-2029 (USD Million)
Table 47 Vaccine Design Market, by Region, 2022-2029 (USD Million)
Table 48 Antibody & Other Biologics Design Market, by Region, 2022-2029 (USD Million)
Table 49 Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 50 Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Region, 2022-2029 (USD Million)
Table 51 Small-Molecule Optimization Market, by Region, 2022-2029 (USD Million)
Table 52 Vaccine Optimization Market, by Region, 2022-2029 (USD Million)
Table 53 Antibody & Other Biologics Optimization Market, by Region, 2022-2029 (USD Million)
Table 54 Artificial Intelligence in Drug Discovery Market for Safety & Toxicity, by Region, 2022-2029 (USD Million)
Table 55 Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 56 Artificial Intelligence in Drug Discovery Market for Oncology, by Region, 2022-2029 (USD Million)
Table 57 Artificial Intelligence in Drug Discovery Market for Infectious Diseases, by Region, 2022-2029 (USD Million)
Table 58 Artificial Intelligence in Drug Discovery Market for Neurology, by Region, 2022-2029 (USD Million)
Table 59 Artificial Intelligence in Drug Discovery Market for Metabolic Diseases, by Region, 2022-2029 (USD Million)
Table 60 Indicative List of Developments in Cardiovascular Drug Development
Table 61 Artificial Intelligence in Drug Discovery Market for Cardiovascular Diseases, by Region, 2022-2029 (USD Million)
Table 62 Artificial Intelligence in Drug Discovery Market for Immunology, by Region, 2022-2029 (USD Million)
Table 63 Artificial Intelligence in Drug Discovery Market for Mental Health Disorders, by Region, 2022-2029 (USD Million)
Table 64 Artificial Intelligence in Drug Discovery Market for Other Therapeutic Areas, by Region, 2022-2029 (USD Million)
Table 65 Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 66 Artificial Intelligence in Drug Discovery Market for End-To-End Solution Providers, by Region, 2022-2029 (USD Million)
Table 67 Artificial Intelligence in Drug Discovery Market for Niche/Point Solution Providers, by Region, 2022-2029 (USD Million)
Table 68 Artificial Intelligence in Drug Discovery Market for AI Technology Providers, by Region, 2022-2029 (USD Million)
Table 69 Artificial Intelligence in Drug Discovery Market for Business Process Service Providers, by Region, 2022-2029 (USD Million)
Table 70 Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 71 Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 72 Artificial Intelligence in Drug Discovery Market for Machine Learning, by Region, 2022-2029 (USD Million)
Table 73 Deep Learning Market, by Region, 2022-2029 (USD Million)
Table 74 Supervised Learning Market, by Region, 2022-2029 (USD Million)
Table 75 Reinforcement Learning Market, by Region, 2022-2029 (USD Million)
Table 76 Unsupervised Learning Market, by Region, 2022-2029 (USD Million)
Table 77 Other Machine Learning Technologies Market, by Region, 2022-2029 (USD Million)
Table 78 Artificial Intelligence in Drug Discovery Market for Natural Language Processing, by Region, 2022-2029 (USD Million)
Table 79 Artificial Intelligence in Drug Discovery Market for Context-Aware Processing & Computing, by Region, 2022-2029 (USD Million)
Table 80 Artificial Intelligence in Drug Discovery Market for Computer Vision, by Region, 2022-2029 (USD Million)
Table 81 Artificial Intelligence in Drug Discovery Market for Image Analysis, by Region, 2022-2029 (USD Million)
Table 82 Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 83 Artificial Intelligence in Drug Discovery Market for On-Premises Deployment, by Region, 2022-2029 (USD Million)
Table 84 Artificial Intelligence in Drug Discovery Market for Cloud-based Deployment, by Region, 2022-2029 (USD Million)
Table 85 Artificial Intelligence in Drug Discovery Market for Saas-based Deployment, by Region, 2022-2029 (USD Million)
Table 86 Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 87 Indicative List of Developments Related to Artificial Intelligence in Pharmaceutical & Biotechnology Industry
Table 88 Artificial Intelligence in Drug Discovery Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 89 Indicative List of Collaborations with Contract Research Organizations
Table 90 Artificial Intelligence in Drug Discovery Market for Contract Research Organizations, by Region, 2022-2029 (USD Million)
Table 91 Indicative List of Collaborations in Research Centers and Academic & Government Institutes
Table 92 Artificial Intelligence in Drug Discovery Market for Research Centers and Academic & Government Institutes, by Region, 2022-2029 (USD Million)
Table 93 Artificial Intelligence in Drug Discovery Market, by Region, 2022-2029 (USD Million)
Table 94 North America: Artificial Intelligence in Drug Discovery Market, by Country, 2022-2029 (USD Million)
Table 95 North America: Artificial Intelligence in Drug Discovery Market, by Process 2022-2029 (USD Million)
Table 96 North America: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 97 North America: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 98 North America: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 99 North America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 100 North America: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 101 North America: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 102 North America: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 103 North America: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 104 North America: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 105 US: Indicative List of Strategic Developments
Table 106 US: Artificial Intelligence in Drug Discovery Market, by Process 2022-2029 (USD Million)
Table 107 US: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 108 US: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 109 US: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 110 US: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 111 US: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 112 US: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 113 US: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 114 US: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 115 US: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 116 Canada: Artificial Intelligence in Drug Discovery Market, by Process 2022-2029 (USD Million)
Table 117 Canada: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 118 Canada: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 119 Canada: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 120 Canada: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 121 Canada: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 122 Canada: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 123 Canada: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 124 Canada: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 125 Canada: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 126 Europe: Artificial Intelligence in Drug Discovery Market, by Country 2022-2029 (USD Million)
Table 127 Europe: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 128 Europe: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 129 Europe: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 130 Europe: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 131 Europe: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 132 Europe: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 133 Europe: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 134 Europe: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 135 Europe: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 136 Europe: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 137 UK: Indicative List of Strategic Developments
Table 138 UK: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 139 UK: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 140 UK: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 141 UK: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 142 UK: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 143 UK: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 144 UK: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 145 UK: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 146 UK: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 147 UK: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 148 Germany: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 149 Germany: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 150 Germany: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 151 Germany: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 152 Germany: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 153 Germany: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 154 Germany: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 155 Germany: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 156 Germany: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 157 Germany: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 158 France: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 159 France: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 160 France: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 161 France: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 162 France: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 163 France: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 164 France: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 165 France: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 166 France: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 167 France: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 168 Italy: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 169 Italy: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 170 Italy: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 171 Italy: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 172 Italy: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 173 Italy: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 174 Italy: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 175 Italy: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 176 Italy: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 177 Italy: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 178 Spain: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 179 Spain: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 180 Spain: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 181 Spain: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 182 Spain: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 183 Spain: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 184 Spain: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 185 Spain: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 186 Spain: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 187 Spain: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 188 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 189 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 190 Rest of Europe: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 191 Rest of Europe: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 192 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 193 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 194 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 195 Rest of Europe: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 196 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 197 Rest of Europe: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 198 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Country 2022-2029 (USD Million)
Table 199 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 200 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 201 Asia-Pacific: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 202 Asia-Pacific: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 203 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 204 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 205 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 206 Asia-Pacific: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 207 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 208 Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 209 Japan: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 210 Japan: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 211 Japan: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 212 Japan: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 213 Japan: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 214 Japan: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 215 Japan: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 216 Japan: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 217 Japan: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 218 Japan: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 219 China: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 220 China: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 221 China: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 222 China: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 223 China: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 224 China: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 225 China: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 226 China: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 227 China: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 228 China: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 229 India: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 230 India: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 231 India: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 232 India: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 233 India: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 234 India: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 235 India: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 236 India: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 237 India: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 238 India: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 239 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 240 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 241 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 242 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 243 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 244 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 245 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 246 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 247 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 248 Rest of Asia-Pacific: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 249 Latin America: Artificial Intelligence in Drug Discovery Market, by Country, 2022-2029 (USD Million)
Table 250 Latin America: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 251 Latin America: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 252 Latin America: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 253 Latin America: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 254 Latin America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 255 Latin America: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 256 Latin America: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 257 Latin America: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 258 Latin America: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 259 Latin America: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 260 Brazil: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 261 Brazil: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 262 Brazil: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 263 Brazil: Artificial Intelligence in Drug Discovery Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 264 Brazil: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 265 Brazil: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 266 Brazil: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 267 Brazil: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 268 Brazil: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 269 Brazil: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 270 Mexico: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 271 Mexico: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 272 Mexico: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 273 Mexico: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 274 Mexico: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 275 Mexico: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 276 Mexico: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 277 Mexico: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 278 Mexico: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 279 Mexico: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 280 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 281 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 282 Rest of Latin America: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 283 Rest of Latin America: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 284 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 285 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 286 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 287 Rest of Latin America: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 288 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 289 Rest of Latin America: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 290 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Region, 2022-2029 (USD Million)
Table 291 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 292 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 293 Middle East & Africa: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 294 Middle East & Africa: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 295 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 296 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 297 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 298 Middle East & Africa: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 299 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 300 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 301 GCC Countries: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 302 GCC Countries: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 303 GCC Countries: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 304 GCC Countries: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 305 GCC Countries: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 306 GCC Countries: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 307 GCC Countries: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 308 GCC Countries: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 309 GCC Countries: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 310 GCC Countries: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 311 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Process, 2022-2029 (USD Million)
Table 312 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Use Case, 2022-2029 (USD Million)
Table 313 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market for De Novo Drug Design, by Type, 2022-2029 (USD Million)
Table 314 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market for Drug Optimization, by Type, 2022-2029 (USD Million)
Table 315 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 316 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Player Type, 2022-2029 (USD Million)
Table 317 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by AI Tool, 2022-2029 (USD Million)
Table 318 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market for Machine Learning, by Type, 2022-2029 (USD Million)
Table 319 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Deployment, 2022-2029 (USD Million)
Table 320 Rest of Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by End-user, 2022-2029 (USD Million)
Table 321 Overview of Strategies Adopted by Key Players in Artificial Intelligence in Drug Discovery Market, January 2021-October 2024
Table 322 Artificial Intelligence in Drug Discovery Market: Degree of Competition
Table 323 Artificial Intelligence in Drug Discovery Market: Use Case Footprint
Table 324 Artificial Intelligence in Drug Discovery Market: Process Footprint
Table 325 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Footprint
Table 326 Artificial Intelligence in Drug Discovery Market: Player Type Footprint
Table 327 Artificial Intelligence in Drug Discovery Market: Deployment Mode Footprint
Table 328 Artificial Intelligence in Drug Discovery Market: Region Footprint
Table 329 Artificial Intelligence in Drug Discovery Market: Detailed List of Key Startup/SME Players
Table 330 Artificial Intelligence in Drug Development Market: Competitive Benchmarking of Key Emerging Players/Startups, by Region
Table 331 Artificial Intelligence in Drug Discovery Market: Product and Solution Launches, January 2021-October 2024
Table 332 Artificial Intelligence in Drug Discovery Market: Deals, January 2021-October 2024
Table 333 Artificial Intelligence in Drug Discovery Market: Expansions, January 2021-October 2024
Table 334 Artificial Intelligence in Drug Discovery Market: Other Developments, January 2021-October 2024
Table 335 Nvidia Corporation: Company Overview
Table 336 Nvidia Corporation: Products/Services/Solutions Offered
Table 337 Nvidia Corporation: Product and Service Launches, January 2021-October 2024
Table 338 Nvidia Corporation: Deals, January 2021-October 2024
Table 339 Exscientia: Company Overview
Table 340 Exscientia: Products/Services/Solutions Offered
Table 341 Exscientia: Solution Launches, January 2021-October 2024
Table 342 Exscientia: Deals, January 2021-October 2024
Table 343 Exscientia: Expansions, January 2021-October 2024
Table 344 Exscientia: Other Developments, January 2021-October 2024
Table 345 Google: Company Overview
Table 346 Google: Products/Services/Solutions Offered
Table 347 Google: Solution Launches, January 2021-October 2024
Table 348 Google: Deals, January 2021-October 2024
Table 349 Google: Expansions, January 2021-October 2024
Table 350 Recursion: Company Overview
Table 351 Recursion: Products/Services/Solutions Offered
Table 352 Recursion: Solution Launches, January 2021-October 2024
Table 353 Recursion: Deals, January 2021-October 2024
Table 354 Recursion: Expansions, January 2021-October 2024
Table 355 Insilico Medicine: Company Overview
Table 356 Insilico Medicine: Products/Services/Solutions Offered
Table 357 Insilico Medicine: Product and Solution Launches and Developments, January 2021-October 2024
Table 358 Insilico Medicine: Deals, January 2021-October 2024
Table 359 Insilico Medicine: Other Developments, January 2021-October 2024
Table 360 Schrödinger, Inc.: Company Overview
Table 361 Schrödinger, Inc.: Products/Services/Solutions Offered
Table 362 Schrödinger, Inc.: Deals, January 2021-October 2024
Table 363 Schrödinger, Inc.: Other Developments, January 2021-October 2024
Table 364 Benevolentai: Company Overview
Table 365 Benevolentai: Products/Services/Solutions Offered
Table 366 Benevolentai: Deals, January 2021-October 2024
Table 367 Microsoft Corporation: Company Overview
Table 368 Microsoft Corporation: Products/Services/Solutions Offered
Table 369 Microsoft Corporation: Deals, January 2021-October 2024
Table 370 Atomwise Inc.: Company Overview
Table 371 Atomwise Inc.: Products/Services/Solutions Offered
Table 372 Atomwise Inc.: Deals, January 2021-October 2024
Table 373 Illumina, Inc.: Company Overview
Table 374 Illumina, Inc.: Products/Services/Solutions Offered
Table 375 Illumina, Inc.: Solution Launches, January 2021-October 2024
Table 376 Illumina, Inc.: Deals, January 2021-October 2024
Table 377 Numedii, Inc.: Company Overview
Table 378 Numedii, Inc.: Products/Services/Solutions Offered
Table 379 Xtalpi Inc.: Company Overview
Table 380 Xtalpi Inc.: Products/Services/Solutions Offered
Table 381 Xtalpi Inc.: Deals, January 2021-October 2024
Table 382 Iktos: Company Overview
Table 383 Iktos: Products/Services/Solutions Offered
Table 384 Iktos: Deals, January 2021-October 2024
Table 385 Iktos: Other Developments, January 2021-October 2024
Table 386 Tempus: Company Overview
Table 387 Tempus: Products/Services/Solutions Offered
Table 388 Tempus: Solution Launches, January 2021-October 2024
Table 389 Tempus: Deals, January 2021-October 2024
Table 390 Tempus: Expansions, January 2021-October 2024
Table 391 Tempus: Other Developments, January 2021-October 2024
Table 392 Deep Genomics: Company Overview
Table 393 Deep Genomics: Products/Services/Solutions Offered
Table 394 Deep Genomics: Solution Launches, January 2021-October 2024
Table 395 Deep Genomics: Deals, January 2021-October 2024
Table 396 Deep Genomics: Other Developments, January 2021-October 2024
Table 397 Verge Genomics: Company Overview
Table 398 Verge Genomics: Products/Services/Solutions Offered
Table 399 Verge Genomics: Deals, January 2021-October 2024
Table 400 Benchsci: Company Overview
Table 401 Benchsci: Products/Services/Solutions Offered
Table 402 Benchsci: Solution Launches, January 2021-October 2024
Table 403 Benchsci: Deals, January 2021-October 2024
Table 404 Benchsci: Other Developments, January 2021-October 2024
Table 405 Insitro: Company Overview
Table 406 Insitro: Products/Services/Solutions Offered
Table 407 Insitro: Deals, January 2021-October 2024
Table 408 Insitro: Other Developments, January 2021-October 2024
Table 409 Valo Health: Company Overview
Table 410 Valo Health: Products/Services/Solutions Offered
Table 411 Valo Health: Deals, January 2021-October 2024
Table 412 Valo Health: Other Developments, January 2021-October 2024
Table 413 Bpgbio, Inc.: Company Overview
Table 414 Bpgbio, Inc.: Products/Services/Solutions Offered
Table 415 Bpgbio, Inc.: Deals, January 2021-October 2024
Table 416 Merck KGaA: Company Overview
Table 417 Merck KGaA: Products/Services/Solutions Offered
Table 418 Merck KGaA: Solution Launches, January 2021-October 2024
Table 419 Merck KGaA: Deals, January 2021-October 2024
Table 420 Merck KGaA: Expansions, January 2021-October 2024
Table 421 Merck KGaA: Other Developments, January 2021-October 2024
Table 422 Predictive Oncology: Company Overview
Table 423 Iqvia Inc.: Company Overview
Table 424 Tencent Holdings Limited: Company Overview
Table 425 Cytoreason Ltd.: Company Overview
Table 426 Owkin, Inc.: Company Overview
Table 427 Cloud Pharmaceuticals: Company Overview
Table 428 Evaxion Biotech A/S: Company Overview
Table 429 Standigm Inc.: Company Overview
Table 430 Bioage Labs: Company Overview
Table 431 Envisagenics: Company Overview
Table 432 Abcellera: Company Overview
Table 433 Centella: Company Overview

Figure 1 Artificial Intelligence in Drug Discovery Market: Segments and Regions Considered
Figure 2 Artificial Intelligence in Drug Discovery Market: Years Considered
Figure 3 Artificial Intelligence in Drug Discovery Market: Research Design
Figure 4 Artificial Intelligence in Drug Discovery Market: Key Data from Secondary Sources
Figure 5 Artificial Intelligence in Drug Discovery Market: Key Primary Sources
Figure 6 Artificial Intelligence in Drug Discovery Market: Key Data from Primary Sources
Figure 7 Artificial Intelligence in Drug Discovery Market: Key Industry Insights
Figure 8 Breakdown of Primary Interviews: by Demand Side, Supply Side, Designation, and Region
Figure 9 Research Methodology: Hypothesis Building
Figure 10 Supply-Side Market Estimation: Revenue Share Analysis
Figure 11 Artificial Intelligence in Drug Discovery Market: Revenue Share Analysis Illustration
Figure 12 Bottom-Up Approach: End-user Spending on Artificial Intelligence in Drug Discovery
Figure 13 CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges (2024-2029)
Figure 14 CAGR Projections: Supply-Side Analysis
Figure 15 Artificial Intelligence in Drug Discovery Market: Top-Down Approach
Figure 16 Artificial Intelligence in Drug Discovery Market: Data Triangulation
Figure 17 Artificial Intelligence in Drug Discovery Market, by Process, 2024 vs. 2029 (USD Million)
Figure 18 Artificial Intelligence in Drug Discovery Market, by Use Case, 2024 vs. 2029 (USD Million)
Figure 19 Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2024 vs. 2029 (USD Million)
Figure 20 Artificial Intelligence in Drug Discovery Market, by Player Type, 2024 vs. 2029 (USD Million)
Figure 21 Artificial Intelligence in Drug Discovery Market, by AI Tool, 2024 vs. 2029 (USD Million)
Figure 22 Artificial Intelligence in Drug Discovery Market, by Deployment, 2024 vs. 2029 (USD Million)
Figure 23 Artificial Intelligence in Drug Discovery Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 24 Artificial Intelligence in Drug Discovery Market: Regional Snapshot
Figure 25 Increasing Number of Cross-Industry Collaborations and Partnerships to Drive Market
Figure 26 US and Pharmaceutical & Biotechnology Companies Commanded Largest Market Share in 2023
Figure 27 India to Register Highest Growth Rate from 2024 to 2029
Figure 28 North America to Dominate Market During Forecast Period
Figure 29 Emerging Markets to Register Higher Growth Rates During Study Period
Figure 30 Artificial Intelligence in Drug Discovery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 31 Cost of Genome Analysis vs. Levels of Raw Data Generated, 2003-2023
Figure 32 Approval of Personalized Medicines by US Fda, 2015-2023
Figure 33 Artificial Intelligence in Drug Discovery Market: Trends/Disruptions Impacting Customer's Business
Figure 34 Evolution of AI in Drug Discovery Market
Figure 35 Artificial Intelligence in Drug Discovery Market: Structure-based Drug Designing
Figure 36 Artificial Intelligence in Drug Discovery Market: Ecosystem Analysis
Figure 37 Artificial Intelligence in Drug Discovery Market: Supply Chain Analysis
Figure 38 Artificial Intelligence in Drug Discovery Market: Types of Service
Figure 39 Artificial Intelligence in Drug Discovery Market: Porter's Five Forces Analysis
Figure 40 Influence of Stakeholders on Buying Process for End-users
Figure 41 Key Buying Criteria for Top Three End-users
Figure 42 Jurisdiction Analysis: Top Applicant Countries for “AI in Drug Discovery” Patents (January 2015-September 2024)
Figure 43 Major Patents in Artificial Intelligence in Drug Discovery Market (January 2015-September 2024)
Figure 44 Artificial Intelligence in Drug Discovery Market: Business Models
Figure 45 Benefits of Hybrid Business Models
Figure 46 Specialization of Artificial Intelligence-based Companies Over Time
Figure 47 Funding in Artificial Intelligence in Drug Discovery Market, 2013-2022 (USD Million)
Figure 48 Market Potential of AI/Generative AI in Enhancing Laboratory Informatics Across Industries
Figure 49 Impact of AI/Generative AI on Interconnected and Adjacent Ecosystems
Figure 50 Hit-To-Lead Identification/Lead Generation Segment Held Largest Market Share in 2023
Figure 51 North America: Artificial Intelligence in Drug Discovery Market Snapshot
Figure 52 Distribution of R&D Companies, by Country/Region (2022 vs. 2023)
Figure 53 Asia-Pacific: Artificial Intelligence in Drug Discovery Market Snapshot
Figure 54 Revenue Analysis of Key Players in Artificial Intelligence in Drug Discovery Market (2019-2023)
Figure 55 Market Share Analysis of Key Players in Artificial Intelligence in Drug Discovery Market (2023)
Figure 56 Artificial Intelligence in Drug Discovery Market: Ranking of Key Market Players (2023)
Figure 57 Artificial Intelligence in Drug Discovery Market: Company Evaluation Matrix (Key Players), 2023
Figure 58 Artificial Intelligence in Drug Discovery Market: Company Footprint
Figure 59 Artificial Intelligence in Drug Discovery Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 60 EV/Ebitda of Key Vendors
Figure 61 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 62 Artificial Intelligence in Drug Discovery Market: Brand/Product Comparative Analysis
Figure 63 Nvidia Corporation: Company Snapshot
Figure 64 Exscientia: Company Snapshot
Figure 65 Google: Company Snapshot
Figure 66 Recursion: Company Snapshot
Figure 67 Schrödinger, Inc.: Company Snapshot
Figure 68 Benevolentai: Company Snapshot
Figure 69 Microsoft Corporation: Company Snapshot
Figure 70 Illumina, Inc.: Company Snapshot
Figure 71 Merck KGaA: Company Snapshot